Generic selectors
Exact matches only
Search in title
Search in content

DiMe Virtual Journal Club

To participate in this discussion live, you must be a member of DiMe.

Each month we will select a manuscript tackling an important topic in digital medicine and DiMe members can register to participate in an intimate discussion with the manuscript author(s).

Sessions will take an AMA (“ask me anything”) approach

Immediately after the session, the recording will be posted to a new Slack channel in DiMe’s Workspace. For the next week, we will moderate a discussion in Slack between all of DiMe’s members and the author(s).

To participate in this discussion live, you must be a member of DiMe. 

Upcoming Discussion


Date/Time

May 12, 2022 @ 11:00 am ET

Discussants

Iredia Olaye, Ph.D., MSc., M.S.

Fellow, Weill Cornell Medicine, Cornell University

Carrie Northcott, PhD

Director, Project Lead within Digital Medicine and Translational Imaging (DMTI), Early Clinical Development (ECD) at Pfizer

Ali Ciger

Vaccines Country Lead, Pfizer

Isaac Rodriguez-Chavez, phd, mhsc, msc

SVP, Scientific & Clinical Affairs, Head, Decentralized Clinical Trials & Digital Medicine Strategy at ICON

Mia Belovsky

MD Candidate at Sidney Kimmel Medical College

Recommendations for Defining and Reporting Adherence Measured by Biometric Monitoring Technologies

Connected sensor technologies represent a potential solution to capturing adherence data accurately, objectively, and continually throughout a clinical trial. However, best practices for measuring and reporting adherence to digital health technologies are unclear

The DiMe Research Committee’s latest publication describes the methods and definitions by which adherence has been captured and reported using BioMeTs in recent years. Their work identified nine key recommendations for investigators planning on capturing and reporting adherence data using digital tools. Join us on May 12 at 11 am ET for a fantastic presentation on the Research Committee’s work and recommendations.

Share This Page

Listen to Previous Journal Club Discussions


Identifying the Factors Influencing Patients’ Telehealth Visit Satisfaction: Survey Validation Through a Structural Equation Modeling

Patient experience and expectations have changed after the pandemic, as telehealth is becoming the new norm replacing in-person visits. At our April #AskeMeAnything Journal Club, our colleagues from the Abigail Wexner Research Institute at Nationwide Children’s Hospital will share 2 of their recent studies focusing on telehealth satisfaction survey development, implementation, and validation. 

(1)  The goal of this study was to assess patient satisfaction and assess the quality of services. The team developed a telehealth patient satisfaction survey (TPSS) with a multi-stakeholder group. In this first study, we shared survey components and explained how we developed the survey. We also proposed a conceptual research model to explain patient behavior towards telehealth satisfaction. 

(2)  In the second paper, the team validated their model, the telehealth patient satisfaction model, (TPSM) testing the factors (admission process, perceived quality of service) influencing patient satisfaction.

View the slide deck from April 2022 Journal Club

Watch the recording

Read the publication

Share this webinar

 

Advancing digital health applications: priorities for innovation in real-world evidence (RWE) generation

To accelerate innovation in evidence generation to support broad acceptance of digital health applications, DiMe and the health innovation hub (hih) of the German Federal Ministry of Health is releasing a manuscript end of February to define global priorities in evidence generation related to digital health applications that will speed the use of high-quality digital medicine products in routine care. Over the last year, an international group of researchers and experts in the use of real-world data and real-world evidence generation for digital medicine products joined a set of roundtable discussions and identified innovative approaches to digital medical product evaluation.

Join the co-authors of this manuscript in an open discussion and learn about the methodological challenges and opportunities for this emerging field of research, alongside examples of novel approaches to health evaluation research that can be readily applied to the evaluation of DiGA in Germany and novel digital health applications more broadly globally.

Watch the recording

View the hih DiMe Journal Club Slides

Read the publication

Share this journal club

Sensor Data Integration: A New Cross-Industry Collaboration to Articulate Value, Define Needs, and Advance a Framework for Best Practices

The Digital Medicine Society recently launched a multi-stakeholder Sensor Data Integration Tour of Duty to address these challenges and more, provide a clear direction on how sensor data can fulfill its potential to enhance patient lives. 

Data integration, the processes by which data are aggregated, combined, and made available for use, has been key to the development and growth of many technological solutions. In health care, we are experiencing a revolution in the use of sensors to collect data on patient behaviors and experiences. Yet, the potential of this data to transform health outcomes is being held back. Deficits in standards, lexicons, data rights, permissions, and security have been well documented, less so the cultural adoption of sensor data integration as a priority for large-scale deployment and impact on patient lives. The use and reuse of trustworthy data to make better and faster decisions across drug development and care delivery will require an understanding of all stakeholder needs and best practices to ensure these needs are met. 

Listen in as the co-authors of this paper on sensor data integration in an open discussion and learn more about the new cross-industry collaboration with the aim to articulate value, define needs, and advance a framework for best practices.

Watch the recording

View Slides for this Journal Club

Visit the DiMe Sensor Data Integration webpage

Share this webinar

Listen up! Using digital tools when designing patient-centric clinical trials

The use of digital health technologies in clinical studies introduces unique design complexities, as well as exciting opportunities, to measure what matters to patients. Using Parkinson’s as a case example, the 3DT (Digital Drug Development Tools) team of the Critical Path consortium shares recommendations that integrate the patient voice at every step of the way in order to maximize engagement, optimize recruitment, and increase retention and protocol adherence. The objective of this presentation is to overview a set of guidelines, recommendations, and considerations for integration of DHT, regardless of the type of device, in PD clinical studies in order to improve the overall study design and execution, with the engagement of patients as a key component of this process.

Listen in to the discussion with the panelists:

– Johan Hellsten, PhD, Senior specialist in Patient Insights (R&D), Lundbeck

– Martijn Müller, PhD, Senior Scientific Director, Critical Path for Parkinson’s, Critical Path Institute

– Cindy Zadikoff, MD, Medical Director & CPP Industry Co-Director, AbbVie

– Mark Frasier, MD, Chief Science Officer, Research Programs, Michael J. Fox Foundation

View the presentation slides

Listen to the Recording

Share this journal club

Digital medicine and the curse of dimensionality

A patient’s health state can be characterized by a multitude of signals from many different data modalities. This high-dimensional, personalized data stream aggregated over patients’ lives has spurred interest in developing new clinical AI models. One of the rate-limiting factors in developing AI models that generalize to real-world scenarios is the very attribute that makes the data exciting—their high-dimensional nature.

At DiMe’s #AskMeAnything Journal, author Visar Berisha, PhD led a discussion on how “the curse of dimensionality” can doom models to failure, even when they seem to work well during development. We explored the key highlights of his Nature publication “Digital medicine and the curse of dimensionality“, Visar also provided some suggestions on how to develop clinical AI models that are more likely to fare well during prospective validation.

 

Read the article

Listen to the discussion

View the presentation slides

Share this journal club

 

A Systematic Review of Recent Academic Research on Clinically-Relevant Digital Measures

The collaborators on The Playbook have published findings of a systematic review that identifies the need for more research funding related to digital clinical measures.

Among all its findings, one that stands out is that in the last two years, out of 295 research studies published on digital clinical measures, there was only one academic publication reporting cybersecurity research, one study examining data rights and governance, and zero publications reporting research into the ethical implications of remote patient monitoring tools.

Join the co-authors of this manuscript in a discussion about the current state of funding for academic research and help shape an integrated and coordinated effort across academia, academic partners, and academic funders to establish the field of digital clinical measures as an evidence-based field worthy of our trust.

Read the article

Listen to the discussion

View the presentation slides

Share this journal club

As digital measures become more complex, in terms of 1) the technologies, methods and data used to derive them, and 2) in terms of the aspects of health that they address, computer scientists, electrical engineers and other people coming from a data or computing background are increasingly important members of this village.

What can we do to bridge the gap from data-orientated background to clinical application of their skills? Can a unified lexicon aid communication throughout this process?

Ieuan Clay and Jen Goldsack presented their publication, “It takes a village: development of digital measures for computer scientists” and opened up a discussion on the range of challenges and considerations where computer scientists can have a particular impact on the development of a new digital measure.

>>Watch the recording

>> View the presentation slides

 

 

Why should you report your modeling plan or statistical analysis plan before seeing any data? Why should we all ditch the term ‘statistical significance’ but keep statistical evidence? And how? A fantastic discussion with Eric Daza, Lead Statistician for Digital Health Outcomes at Evidation Health, as he dives into key themes from his recent pieces: Artifice or intelligence? and Ditch ‘statistical significance’.

Our conversation explored two proposed research changes for our field: 1) Splitting all gathered data into a small number of random subsamples to test reproducibility/replicability of results; 2) For exploratory analyses, continue to report CI’s and p-values—but explicitly state as possible uncertainty to expect using new data.

>>Listen to the recording

>>View the presentation slides


Do we fully understand the sensitivity of gait speed as a potential endpoint for clinical trials studies? Matthew D. Czech, Isik Karahanoglu, Xuemei Cai, Charmaine Demanuele, and their colleagues aimed to find out through their recent study, “Age and environment-related differences in gait in healthy adults using wearables” in NPJ. Their work shows that a single lumbar-worn sensor can be used for monitoring gait under free-living conditions and capture meaningful information about real-world functions that might not be possible in controlled settings. Their work also shows that despite higher variability, at-home gait speed was able to capture age-related group differences in healthy volunteers, which were not observed during in-lab gait assessments. Furthermore, they present the statistical methodology for deriving the number of monitoring days required to reliably estimate at-home gait speed that can be used to optimize clinical study design.

>> Click here to read the article

>> Click here to listen to the discussion

>> Click here to view the presentation slides

>> Share this Journal Club

Science is catalyzed by new technology, but the process of technology adoption and implementation typically requires more time and ingenuity than often appreciated. Join us for DiMe’s #AskMeAnything Journal Club with Dr. David Shaywitz as he reviews the life cycle of technology innovations (Perez model), and then introduces five new books he recently reviewed in the Wall Street Journal that attempt to contextualize where we are in the artificial intelligence (AI) journey.

A physician-scientist by training, Dr. Shaywitz has focused his career on biomedical innovation as an operator and investor. In January 2020, he founded Astounding HealthTech, advising senior executives on digital health and connected fitness. He is a lecturer in the Department of Biomedical Informatics at Harvard Medical School, and an adjunct scholar at the American Enterprise Institute in Washington, D.C. He lives in the Boston Area with his wife, three daughters, and a clumber spaniel named Roscoe.

Listen in to this #AskMeAnything Journal event and join the conversation with Dr. Shaywitz and your fellow DiMe colleagues. You can check out his review of several AI books here!

>> Click here to read the article

>> Click here to listen to the discussion

>> Click here to view the presentation slides

>> Share this Journal Club

Did you miss the launch event featuring creators and authors of the EVIDENCE Checklist as well as journal editors and FDA colleagues? Watch it now!

The EVIDENCE (EValuatIng connecteD sENsor teChnologiEs) checklist promotes high-quality reporting in studies where the primary objective is an evaluation of a digital measurement product or its constituent parts. The checklist is a product of DiMe’s most recent Tour of Duty and will be published on May 18.

The EVIDENCE checklist is applicable to five types of evaluations: (1) proof of concept; (2) verification, (3) analytical validation, and (4) clinical validation as defined by the V3 framework; and (5) utility and usability assessments.  Using EVIDENCE, those preparing, reading, or reviewing studies evaluating digital measurement products will be better equipped to distinguish necessary reporting requirements to drive high-quality research. With broad adoption, the EVIDENCE checklist will serve as a much-needed guide to raise the bar for quality reporting in published literature evaluating digital measurement products.

Did you miss it? You can still check out the following:

>> Click here to read the article

>> Click here to listen to the discussion

>> Click here to view the presentation slides

>> Share this Journal Club

With the adoption of digital phenotyping in clinical research and patient care, a common vision for the future of these technologies remains unclear. Listen in to this Journal Club recording with author Anzar Abbas, PhD who opened up a discussion on his work, “Digital Measurement of Mental Health: Challenges, Promises, and Future Directions.” The discussion explored how to classify emerging tools for digital measurement of mental health and discuss the promises and challenges they face.

Anzar Abbas is a neuroscientist focused on developing technology to improve the measurement of health, increase access to care, and inform clinical decision-making using data-driven insights. He is one of the co-creators of OpenDBM, an open-source library of methods in digital phenotyping.

>> Click here to read the article

>> Click here to listen to the discussion

>> Click here to view the presentation slides

>> Share this Journal Club

Digital inclusion as a social determinant of health
Cynthia J. Sieck, et al. npj Digital Medicine volume 4, Article number: 52 (2021)

>> Click here to read the article

>> Click here to listen to the discussion

>> Click here to view the presentation slides

>> Share this Journal Club

“Personalized therapies in the Future of Health: Winning with digital medicine products.” Deloitte Insights. Davis B., Ahmed A., Elsner N., Miranda W. March 2021.

>> Click here to read the article

>> Click here to listen to the discussion

>> Click here to view the presentation slides

>> Share this Journal Club

Perakslis E, Ginsburg GS. Digital Health—The Need to Assess Benefits, Risks, and Value. JAMA. 2021;325(2):127–128

>> Click here to read the article

>> Click here to listen to the discussion

>> Click here to view the presentation slides

>> Share this Journal Club

“Rethinking CMS Coverage And Reimbursement For The Fourth Industrial (AKA Digital) Revolution, ” Health Affairs Blog, October 23, 2020.

>> Click here to read the full article

>> Click here to listen to the discussion

>> Click here to view the presentation slides

>> Share this Journal Club

Narayan VA,et al RADAR-CNS Consortium. “Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19.” J Med Internet Res 2020;22

>> Click here to read the full article

>> Click here to listen to the discussion

>> Click here to view the presentation slides

>> Share this Journal Club

Manta, Christine, Bray Patrick-Lake, and Jennifer C. Goldsack. “Digital Measures That Matter to Patients: A Framework to Guide the Selection and Development of Digital Measures of Health.” Digital Biomarkers 4.3 (2020).

>> Click here to read the full article

>> Click here to listen to the discussion

>> Click here to view the presentation slides

>> Share this Journal Club

Izmailova, E., Godfrey, A. A., Vandendriessche, B., Bakker, J. P., Fitzer‐Attas, C., Gujar, N., Hobbs, M., … & Zipunnikov, V. Clinical and Translational Science. (2020).

>> Click here to read the full article

>> Click here to listen to the discussion

>> Click here to view the presentation slides

>> Share this Journal Club

Gerke, S., Stern, A.D. & Minssen, T. “Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries.” npj Digit. Med. 3, 94 (2020).

>> Click here to read the full article

>> Click here to listen to the discussion

>> Click here to view the presentation slides

>> Share this Journal Club

Rothstein, Mark A., et al. The Journal of Law, Medicine & Ethics 48.1_suppl (2020): 196-226.

 

>> Click here to read the full article

>> Click here to view the presentation slides

>> Share this Journal Club

Indicators of retention in remote digital health studies: a cross-study evaluation of 100,000 participants

Pratap, Abhishek, et al. NPJ digital medicine 3.1 (2020): 1-10.

>> Click here to read the full article

>> Click here to listen to the discussion 

>> Click here to view the presentation slides

>> Share this Journal Club

Bent, B., Goldstein, B.A., Kibbe, W.A. et al. Investigating sources of inaccuracy in wearable optical heart rate sensors. npj Digit. Med. 3, 18 (2020).

 

>> Click here to read the full article

>> Click here to listen to the discussion 

>> Click here to view the presentation slides

>> Share this Journal Club

Mahadevan, N., Patel, S. et al. Development of digital biomarkers for resting tremor and bradykinesia using a wrist-worn wearable device. npj Digit. Med. 3, 5 (2020).

 

>> Click here to read the full article

>> Click here to listen to the discussion 

>> Click here to view the presentation slides

>> Share this Journal Club

Mueller, Arne, et al. “Continuous digital monitoring of walking speed in frail elderly patients: noninterventional validation study and longitudinal clinical trial.” JMIR mHealth and uHealth 7.11 (2019): e15191.

 

>> Click here to read the full article

>> Click here to listen to the discussion

>> Click here to view the presentation slides

>> Share this Journal Club

Sanders, Samantha F., et al. “How Artificial Intelligence Is Changing Health Care Delivery.” NEJM Catalyst 5.5 (2019).

 

>> Click here to read the full article

>> Click here to listen to the discussion

>> Click here to view the presentation slides

>> Share this Journal Club

Digital Medicine Standards 101

Manta, Christine. Sept. 2019. Medium.com

Read the full article

Listen to the discussion

View the presentation slides

Share this journal club

Beau Woods, BS; Andrea Coravos, MBA; Joshua David Corman, BA

Watch the recording

Read the full article

October 2019 JC Slide Deck

Share this Journal Club

Bakker, J. P., Goldsack, J. C., Clarke, M., Coravos, A., Geoghegan, C., Godfrey, A., … & Ramirez, E. (2019).

A systematic review of feasibility studies promoting the use of mobile technologies in clinical research. npj Digital Medicine, 2(1), 47.

Watch the recording

Read the full article

Access CTTI Feasibility Studies Database

Share this Journal Club

Dorsey, E. R., Glidden, A. M., Holloway, M. R.,

Birbeck, G. L., & Schwamm, L. H. (2018).

Teleneurology and mobile technologies: the future of neurological care. Nature Reviews Neurology, 14(5), 285.

 

Watch the recording

Read the full article

Share this Journal Club

Digital Medicine: A Primer on Measurement

Coravos, A., Goldsack, J. C., Karlin, D. R.,

Nebeker, C., Perakslis, E., Zimmerman, N., & Erb,

M. K. (2019). Digital Medicine: A Primer on Measurement. Digital Biomarkers, 3(2), 31-71

Watch the recording

Read the full article

Share this Journal Club

Copyright © 2022 The Digital Medicine Society (DiMe). All Rights Reserved.